APAC

NSC, MTDR ink tattoo removal deal

NSC, MTDR ink tattoo removal deal

The agreement enables clinically supervised access under MKH.

Australia commits $80.33m to 60 medical research projects

The funding spans four national health priorities.

Asia medical waste container market to jump 7.6% by 2034 as healthcare infra expands

Infectious diseases, increased hospital admissions, and medical tourism will cause higher waste volumes in the region.

Digital immunoassays to reach $7.1b by 2036

Protein biomarker assays will remain the largest segment.

Taiwan hospital shortens hospitalisation for 19% of TAVR patients

The workflow cuts ICU use and shortens hospital stays.

Saudi health spending to climb 6.7% CAGR to $98.8b by 2030

Public funding will moderate as private investment accelerates.

Diagnosed head and neck cancer cases in urban China to grow 3.55% annually

The forecast covers newly diagnosed incidence from 2024 to 2034.

Predictive clinical biomarkers market could grow 73% to $14.69b by 2030

MarketsandMarkets estimated a CAGR of 11.6% over the five-year period.

King’s College Hospital deploys Da Vinci Xi for minimally invasive procedures

The system provides 3D visualisation and robotic instrumentation.

Asia-Pacific to see fastest growth in SMRT sequencing through 2030

Thanks to rising public and private investment in genomics.

At-home syphilis test kit market to grow $1.25b

Asia Pacific leads growth in at-home syphilis testing.

Global dental laboratories market projected to reach $13.09b by 2030

Asia Pacific dental labs expected highest CAGR growth.

IoMT market forecast to reach $257.16b by 2030

Chronic disease and remote monitoring will underpin this growth.